Stock screenerAll disclosures →
EDGAR →
CRBP
Conviction 20HealthcareScan · Fri, Jun 26, 2026CRBP$8.70+5.45%
ResistanceSupportVol 14Insider buyVol MA14 433.23K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price8.70
Change+5.45%
Gap+0.85%
Rel volume3.51×
Avg volume512.77K
Avg $ vol4.12M
SMA 207.97
SMA 509.37
SMA 20010.19
Price vs 50-7.13%
Price vs 200-14.66%
MA stackbearish
50/200 cross—
Supertrenddown · 9.73
RSI (14)52
MACD hist0.16
MACD crossbull · 8d
Stoch %K / %D96 / 72
ADX (14)10
+DI / −DI23 / 21
RSI divergence—
MACD divergence—
ATR %+7.11%
ADR %5.86%
52w high19.36
52w low6.90
From 52w high-55.06%
Above 52w low+26.09%
New 52w highNo
SqueezeOff
Bollinger width17.31%
%B1.03
Donchian pos96.93%
Donchian high8.75
Donchian low7.12
AVWAP (52w high)10.09
vs AVWAP high-13.81%
AVWAP (52w low)10.34
vs AVWAP low-15.90%
OBV trendUp
Chaikin MF (20)0.02
Today vs 20d3.51×
Avg vol (14d)433.23K
Avg vol (20d)512.77K
Avg $ vol (20d)4.12M
Market cap—
RS 3m (vs SPY)-12.52%
RS 6m (vs SPY)-8.30%
RS line new highNo
Trend template0/8
Technical rank44.4
1 week+5.33%
1 month+11.25%
3 months-5.84%
6 months+6.23%
1 year+0.35%
YTD+10.55%
P/E-1.95
P/B1.21
P/S—
P/FCF-2.37
EPS-5.90
Div yield—
ROE-62.16%
ROA-54.36%
Debt/Eq0.10
Current7.92
EV/EBITDA-1.65
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-95.32%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value139.96M
Revenue0
Net income-22.97M
Gross profit—
Free cash flow-64.5M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out18.53M
Employees36
ListedFri, Oct 24, 2014
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank44.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance12.64
Support7.29
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CRBP
No recent disclosed trades by Congress in CRBP. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CRBP · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Saxena Nishant C Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-06-03 | Buy | 9K | $68K | 2026-06-03 | 2026-06-03 |
Saxena Nishant C Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-06-02 | Buy | 4.5K | $33K | 2026-06-02 | 2026-06-03 |
Saxena Nishant C Chief Business Officer · Common Stock, par value $0.0001 per share · 2026-05-21 | Grant | 58.3K | $0 | 2026-05-21 | 2026-05-22 |
Saxena Nishant C Chief Business Officer · Stock options (right to buy) · 2026-05-21 | Grant | 192.3K | $0 | 2026-05-21 | 2026-05-22 |
Kung Winston Director · Stock options (right to buy) · 2026-05-19 | Grant | 12.3K | $0 | 2026-05-19 | 2026-05-21 |
Ben Yong Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
Jacques Rachelle Suzanne Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
Altmeyer Anne Director · Stock options (right to buy) · 2026-05-19 | Grant | 12.3K | $0 | 2026-05-19 | 2026-05-21 |
Jenkins John Kenneth Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
Altmeyer Anne Director · Common Stock, par value $0.0001 per share · 2026-05-19 | Grant | 3.8K | $0 | 2026-05-19 | 2026-05-21 |
SEC filings
EDGAR filings in CRBP
No recent SEC filings on file for CRBP.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.